IP Library Patent Application 14767218
Patent Application
App. No. 14/767,218

DIFLUPREDNATE EMULSION COMPOSITION CONTAINING ANTIMICROBIAL METAL

Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US None
App. No.
14/767,218
Abstract

The present invention provides a difluprednate emulsion composition showing immediate effectiveness of preservative efficacy. The immediate effectiveness of preservative efficacy is achieved by adding an antimicrobial metal (excluding zinc). The present invention also provides a method of conferring immediate effectiveness of the preservative efficacy to an emulsion composition comprising difluprednate, the method includes preparing an emulsion composition comprising difluprednate and an antimicrobial metal (excluding zinc).

Claims (23)

1 . An emulsion composition comprising difluprednate and an antimicrobial metal (excluding zinc).

2 . The emulsion composition according to claim 1 , wherein the antimicrobial metal (excluding zinc) is a salt or complex of an antimicrobial metal (excluding zinc).

3 . The emulsion composition according to claim 2 , wherein the salt or complex of the antimicrobial metal (excluding zinc) is a salt or complex of at least one antimicrobial metal selected from the group consisting of silver and copper.

4 . The emulsion composition according to claim 3 , wherein the salt or complex of the antimicrobial metal (excluding zinc) is a silver salt or silver complex.

5 . The emulsion composition according to claim 4 , wherein the silver salt or silver complex is at least one selected from the group consisting of silver nitrate, silver protein and phytic acid silver complex.

6 . The emulsion composition according to claim 4 , wherein the silver salt or silver complex has a silver ion concentration of not less than 0.00005 (w/v) % and not more than 0.6 (w/v) %.

7 . The emulsion composition according to claim 4 , wherein the silver salt or silver complex has a silver ion concentration of not less than 0.0005 (w/v) % and not more than 0.01 (w/v) %.

8 . The emulsion composition according to claim 3 , wherein the salt or complex of the antimicrobial metal (excluding zinc) is a copper salt or copper complex.

9 . The emulsion composition according to claim 8 , wherein the copper salt or copper complex is copper sulfate.

10 . The emulsion composition according to claim 8 , wherein the copper salt or copper complex has a copper ion concentration of higher than 0.0001 (w/v) % and not more than 0.5 (w/v) %.

11 . The emulsion composition according to claim 8 , wherein the copper salt or copper complex has a copper ion concentration of not less than 0.0005 (w/v) % and not more than 0.01 (w/v) %.

12 . (canceled)

13 . A method of conferring immediate effectiveness of preservative efficacy to an emulsion composition comprising difluprednate, the method comprising preparing an emulsion composition comprising difluprednate and an antimicrobial metal (excluding zinc).

14 . The method according to claim 13 , wherein the immediate effectiveness of preservative efficacy is a decrease in the viable cell count by 3 log or more within 24 hr after inoculation.

15 . The method according to claim 13 , wherein the immediate effectiveness of preservative efficacy is a decrease in the viable cell count by 3 log or more within 24 hr after inoculation and a decrease in the viable cell count by 2 log or more within 6 hr after inoculation.

16 . The method according to claim 13 , wherein the antimicrobial metal (excluding zinc) is a salt or complex of an antimicrobial metal (excluding zinc).

17 . The method according to claim 16 , wherein the salt or complex of the antimicrobial metal (excluding zinc) is a salt or complex of at least one antimicrobial metal selected from the group consisting silver and copper.

18 . The method according to claim 17 , wherein the salt or complex of the antimicrobial metal (excluding zinc) is a silver salt or silver complex.

19 . The method according to claim 18 , wherein the silver salt or silver complex is at least one selected from the group consisting of silver nitrate, silver protein and phytic acid silver complex.

20 .- 21 . (canceled)

22 . The method according to claim 17 , wherein the salt or complex of the antimicrobial metal (excluding zinc) is a copper salt or copper complex.

23 . The method according to claim 22 , wherein the copper salt or copper complex is copper sulfate.

24 .- 26 . (canceled)

Assignments (2)
CHANGE OF ADDRESS Recorded Aug 24, 2018
From: SENJU PHARMACEUTICAL CO., LTD.
To: SENJU PHARMACEUTICAL CO., LTD.
Reel/Frame 046835/0350 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Oct 30, 2015
From: YAMAGUCHI, MASAZUMI; NISHIHATA, SHUICHI; IEMOTO, SUZUKA; YASUEDA, SHINICHI
To: SENJU PHARMACEUTICAL CO., LTD.
Reel/Frame 036925/0159 →